Literature DB >> 17700532

Atm is a negative regulator of intestinal neoplasia.

L N Kwong1, K R Weiss, K M Haigis, W F Dove.   

Abstract

The ataxia telangiectasia-mutated (ATM) gene has been implicated as an early barrier to the growth and progression of incipient solid tumors. Here, we show that germ-line nullizygosity for the mouse Atm gene significantly increases the proliferative index, net growth rate and multiplicity of intestinal adenomas in two distinct models of familial colon cancer: Apc(Min/+) and Apc(1638N/+). These effects of Atm deficiency are quantitatively different from deficiency for either of the genomic stability genes Bloom's syndrome helicase or DNA ligase 4, and the effect of Atm loss on tumor multiplicity is largely independent of the effect of ionizing radiation. Furthermore, the loss of heterozygosity rates at the adenomatous polyposis coli (Apc) locus are unaffected by Atm loss. Taken together, these data implicate the Atm gene product as a barrier to dysplastic growth in the early stages of intestinal tumor progression, independent of its effects on genomic stability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700532      PMCID: PMC2266837          DOI: 10.1038/sj.onc.1210708

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  Mouse models of gastrointestinal tumors.

Authors:  Makoto Mark Taketo
Journal:  Cancer Sci       Date:  2006-05       Impact factor: 6.716

2.  Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability.

Authors:  Chinthalapally V Rao; Yang-Ming Yang; Malisetty V Swamy; Tongyi Liu; Yuqiang Fang; Radma Mahmood; Meena Jhanwar-Uniyal; Wei Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

3.  APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.

Authors:  Klaus-Peter Janssen; Paola Alberici; Hafida Fsihi; Claudia Gaspar; Cor Breukel; Patrick Franken; Christophe Rosty; Miguel Abal; Fatima El Marjou; Ron Smits; Daniel Louvard; Riccardo Fodde; Sylvie Robine
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

4.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.

Authors:  Jirina Bartkova; Nousin Rezaei; Michalis Liontos; Panagiotis Karakaidos; Dimitris Kletsas; Natalia Issaeva; Leandros-Vassilios F Vassiliou; Evangelos Kolettas; Katerina Niforou; Vassilis C Zoumpourlis; Munenori Takaoka; Hiroshi Nakagawa; Frederic Tort; Kasper Fugger; Fredrik Johansson; Maxwell Sehested; Claus L Andersen; Lars Dyrskjot; Torben Ørntoft; Jiri Lukas; Christos Kittas; Thomas Helleday; Thanos D Halazonetis; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

5.  Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome.

Authors:  Michael B Mann; Craig A Hodges; Ellen Barnes; Hannes Vogel; Terry J Hassold; Guangbin Luo
Journal:  Hum Mol Genet       Date:  2005-02-09       Impact factor: 6.150

6.  Somatic genetic events linked to the Apc locus in intestinal adenomas of the Min mouse.

Authors:  C Luongo; W F Dove
Journal:  Genes Chromosomes Cancer       Date:  1996-11       Impact factor: 5.006

7.  Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.

Authors:  Heike Grabsch; Mit Dattani; Lisa Barker; Nicola Maughan; Karen Maude; Olaf Hansen; Helmut E Gabbert; Phil Quirke; Wolfram Mueller
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

8.  A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer.

Authors:  James M Amos-Landgraf; Lawrence N Kwong; Christina M Kendziorski; Mark Reichelderfer; Jose Torrealba; Jamey Weichert; Jill D Haag; Kai-Shun Chen; Jordy L Waller; Michael N Gould; William F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

9.  atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity.

Authors:  C H Westphal; S Rowan; C Schmaltz; A Elson; D E Fisher; P Leder
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

10.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

Authors:  Anthony Renwick; Deborah Thompson; Sheila Seal; Patrick Kelly; Tasnim Chagtai; Munaza Ahmed; Bernard North; Hiran Jayatilake; Rita Barfoot; Katarina Spanova; Lesley McGuffog; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-07-09       Impact factor: 38.330

View more
  10 in total

1.  Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.

Authors:  Li Xu; Elaine Cristina Morari; Qingyi Wei; Erich M Sturgis; Laura S Ward
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

Review 2.  The path to metastatic mouse models of colorectal cancer.

Authors:  Gabriele Romano; Sharmeen Chagani; Lawrence N Kwong
Journal:  Oncogene       Date:  2018-02-21       Impact factor: 9.867

3.  Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.

Authors:  Alejo Efeyan; Matilde Murga; Barbara Martinez-Pastor; Ana Ortega-Molina; Rebeca Soria; Manuel Collado; Oscar Fernandez-Capetillo; Manuel Serrano
Journal:  PLoS One       Date:  2009-05-07       Impact factor: 3.240

4.  Tumor suppression by p53 in the absence of Atm.

Authors:  S Lawrence Bailey; Kay E Gurley; Kyung Hoon-Kim; Karen S Kelly-Spratt; Christopher J Kemp
Journal:  Mol Cancer Res       Date:  2008-06-26       Impact factor: 5.852

5.  Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis.

Authors:  Andrea Bilger; Ruth Sullivan; Amy J Prunuske; Linda Clipson; Norman R Drinkwater; William F Dove
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

Review 6.  Tug of war between survival and death: exploring ATM function in cancer.

Authors:  Venturina Stagni; Veronica Oropallo; Giulia Fianco; Martina Antonelli; Irene Cinà; Daniela Barilà
Journal:  Int J Mol Sci       Date:  2014-03-27       Impact factor: 5.923

Review 7.  Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy.

Authors:  Gwenola Manic; Florine Obrist; Antonella Sistigu; Ilio Vitale
Journal:  Mol Cell Oncol       Date:  2015-02-23

Review 8.  The importance of p53 pathway genetics in inherited and somatic cancer genomes.

Authors:  Giovanni Stracquadanio; Xuting Wang; Marsha D Wallace; Anna M Grawenda; Ping Zhang; Juliet Hewitt; Jorge Zeron-Medina; Francesc Castro-Giner; Ian P Tomlinson; Colin R Goding; Kamil J Cygan; William G Fairbrother; Laurent F Thomas; Pål Sætrom; Federica Gemignani; Stefano Landi; Benjamin Schuster-Böckler; Douglas A Bell; Gareth L Bond
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

9.  The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.

Authors:  Charles E Patek; Mark J Arends; Lorraine Rose; Feijun Luo; Marion Walker; Paul S Devenney; Rachel L Berry; Nicola J Lawrence; Rachel A Ridgway; Owen J Sansom; Martin L Hooper
Journal:  BMC Gastroenterol       Date:  2008-06-13       Impact factor: 3.067

10.  Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition.

Authors:  Ronan Russell; Lukas Perkhofer; Stefan Liebau; Qiong Lin; André Lechel; Fenja M Feld; Elisabeth Hessmann; Jochen Gaedcke; Melanie Güthle; Martin Zenke; Daniel Hartmann; Guido von Figura; Stephanie E Weissinger; Karl-Lenhard Rudolph; Peter Möller; Jochen K Lennerz; Thomas Seufferlein; Martin Wagner; Alexander Kleger
Journal:  Nat Commun       Date:  2015-07-29       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.